COPD

Since the start of the pandemic, many patients with COPD, especially if they experienced an exacerbation during 2020, reported adopting telemedicine, according to a recent study.

A recent study found that patients with both chronic obstructive pulmonary disease (COPD) and diabetes using oral hypoglycemic agents had lower risks of severe exacerbations than controls.

The panel was charged with deciding if the benefits of the vaccine outweighs the risks, paving the way for the possibility that immunizations could begin within days.

Clinics that offer a multidisciplinary team-based approach to treat chronic obstructive pulmonary disease (COPD) can provide patients in rural areas access to care and improve their health.

A review found that including exercise, breathing techniques, and education components in pulmonary rehabilitation for patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) optimizes such programs.

A study on patients who use inhalers found that interventions to improve inhaler techniques and drug adherence are needed.

A recent study found that high-flow nasal cannula may be a better option for first-line oxygen therapy for patients with chronic obstructive pulmonary disease with acute compensated hypercapnic respiratory failure than conventional therapy options.

Patients with chronic obstructive pulmonary disease (COPD) may experience a difference in symptom severity depending on which risk factors they are exposed to across their lifetime.

While patients with severe chronic obstructive pulmonary disease (COPD) are receiving referrals for pulmonary rehabilitation (PR), female patients and other groups are less likely to receive them.

A study looking at chronic obstructive pulmonary disease (COPD) and coronary heart disease found that inhaled corticosteroids (ICS) reduced future cardiac events in patients not known to have coronary heart disease.

Switching patients from pressurized metered dose inhalers (pMDIs) to dry powder inhalers (DPIs) could both reduce health care system’s carbon footprint and result in more satisfied patients.

Combination bronchodilators are available and have been shown to improve both symptoms and lung function, explained Nicola Hanania, MD, MS, of Baylor College of Medicine.

Two CHEST 2020 abstracts looked at mortality risks for patients with chronic obstructive pulmonary disease (COPD).

Major issues still surround COPD treatment, noted Nicola Hanania, MD, MS, pulmonary critical care physician and director, Airway Clinical Research Center, Baylor College of Medicine, Houston, Texas.

A study analyzed the personal and family history of patients who developed chronic obstructive pulmonary disease (COPD) before age 50.

A new national study is highlighting disparities in morbidity and barriers to care that face patients with chronic obstructive pulmonary disease (COPD) living in in rural areas.

While researchers found short periods of acute exercise did not significantly increase circulating concentrations of fibrinogen and C-reactive protein in patients with COPD, they did observe increases in total leukocyte and blood neutrophil counts.

Just 24.7% of elderly patients with chronic obstructive pulmonary disease (COPD) included in the study demonstrated correct usage of their inhaler.

This is the first large observational study to assess the relationship between accelerated forced expiratory volume in 1 second decline and the risk of cardiovascular disease (CVD) outcomes and mortality for patients with chronic obstructive pulmonary disease (COPD).

The researchers found that just 13% of participating providers adhered to the recommended low dose (40 mg) of oral prednisone for patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD).

Data from a meta-analysis suggest chronic obstructive pulmonary disease (COPD) could increase the risk of long-term all-cause mortality for patients with heart failure.

Researchers found that 12% of patients underwent testing even after care teams determined they were actively dying of chronic obstructive pulmonary disease (COPD) and the aim of care shifted to comfort.

The findings have implications for patient self-management of their chronic disease, and clinicians should screen for worsened cognitive function, the researchers wrote.

The assessment of chronic obstructive pulmonary disease (COPD) now allows for the evaluation of various patient-reported outcomes (PROs); however, these PROs assess different disease features than exercise test outcomes.

The same group of patients had their homocysteine level tested when their COPD was exacerbated and also when it was not.

Remote patient monitoring of patients with COPD can offer clues about what happens before an exacerbation.

A review on the diagnosis, prevalence, and clinical impact of sarcopenia in chronic obstructive pulmonary disease (COPD) has found that sarcopenia is both prevalent and negatively impacts clinical outcomes in patients with the disease.

Can muscle mass predict whether patients with chronic obstructive pulmonary disease have a longer hospital stay?

Researchers sought to determine the influence of geographic distance from a hospital on patients' length of stay or emergency department presentation for chronic obstructive pulmonary disease.

Advanced age, prolonged use of non-invasive ventilation (NIV), and unsuccessful response to NIV are independent predictors for long-term mortality in chronic obstructive pulmonary disease (COPD), according to a recent report.